Partnering NSAIDs with Immunotherapy to Fight Cancer – Drug Discovery & Development
Drug Discovery & Development |
Partnering NSAIDs with Immunotherapy to Fight Cancer
Drug Discovery & Development COX-2 is overexpressed in most solid tumors, and is associated with resistance to apoptosis and cancer immunotherapy, while selective COX-2 inhibitors can inhibit cell proliferation, tumor invasiveness, and angiogenesis. The impact of COX-2 inhibitors … |
